MET241213P84000
- 0.93
- +0.07+8.14%
MetLife Newsroom
Morgan Stanley Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $100
TD Cowen Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $99
Jefferies Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $101
32% Of This MetLife Insider's Holdings Were Sold
A Quick Look at Today's Ratings for MetLife(MET.US), With a Forecast Between $90 to $102
TD Cowen Remains a Buy on Metlife (MET)
MetLife's 'New Frontier' Plan and Strategic Shifts Drive Buy Rating and Increased Price Objective
Metlife (MET) Receives a Buy From Barclays
MetLife Weighs Private Credit M&A to Bolster Earnings Growth
Top Stock Movers Now: Adobe, MetLife, Oxford Industries, and More
Sector Update: Financial Stocks Lean Lower Premarket Thursday
MetLife (MET.US) aims for double-digit growth in adjusted earnings per share over the next five years.
According to a report by Reuters, Michel Khalaf, the CEO of MetLife (MET.US), stated that the goal is to achieve double-digit adjusted earnings per share growth in the next five years by increasing investments in core areas such as group benefits and asset management. Khalaf mentioned that the new five-year strategy plan aims not only for earnings per share growth but also for an adjusted return on equity of 15% to 17% and a reduction of direct expense ratio by one percentage point. To achieve these goals, MetLife is prioritizing the development of four existing business areas, including developing the department that provides group benefits insurance to employers, as well as in Latin America.
Sector Update: Financial
MetLife Targets Adjusted ROE of 15%-17% in New Long-term Plan
MetLife Investor Day Webcast At 8:30 AM ET
MetLife Unveils New Frontier Growth Strategy
Express News | MetLife Inc: Five-Year Growth Strategy to Support Consistent Delivery of Free Cash Flow of $25 Bln
Express News | MetLife Inc: Long-Term Financial Commitments Including Double-Digit Adjusted Earnings per Share Growth
Express News | MetLife Unveils New Frontier Growth Strategy and Long-Term Financial Commitments at 2024 Investor Day
KBW Maintains MetLife(MET.US) With Buy Rating, Maintains Target Price $97